{"nct_id":"NCT05445843","title":"Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-12-06","start_date_type":"ACTUAL","primary_completion_date":"2024-11-04","primary_completion_date_type":"ACTUAL","completion_date":"2027-11-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NVS"]}